Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shinji Oda

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Brain and Nerve = Shinkei Kenkyu No Shinpo|October 7, 2021
[Intravascular Large B-cell Lymphoma]Shinji Oda, Masaki Takao
Chemical Communications (Cambridge, England)|February 7, 2008
A novel chiral porous metal-organic framework: asymmetric ring opening reaction of epoxide with amine in the chiral open spaceKoichi Tanaka, Shinji Oda, Motoo Shiro
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|September 1, 2024
[Risk Factors Analysis for Hypermagnesemia with Magnesium Oxide]Shinji Oda, Takayuki Miyoshi, Kenshi Takechi, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|March 1, 2026
[Relationship between Hypercalcemia and Renal Function with Eldecalcitol]Shinji Oda, Takayuki Miyoshi, Kenichi Furuta, et al.
European Journal of Clinical Pharmacology|April 3, 2023
Association between nocturnal falls and hypnotic drug use in older patients at acute care hospitalsShinji Oda, Kenshi Takechi, Satoru Hirai, et al.
Rinsho Shinkeigaku = Clinical Neurology|May 20, 2021
[Amyotrophic lateral sclerosis with muscle weakness and dropped head during the course of Parkinson's disease: an autopsy case]Shinji Oda, Terunori Sano, Noriko Nishikawa, et al.
Journal of Pharmaceutical Health Care and Sciences|October 28, 2025
Risk factors for falls in patients treated with chemotherapyShinji Oda, Kenshi Takechi, Chiyuki Tsukui, et al.
Brain & Development|November 16, 2021
A case of delayed diagnosis of Becker muscular dystrophy due to underlying developmental disordersShinji Oda, Madoka Mori-Yoshimura, Yasushi Oya, et al.
Parkinsonism & Related Disorders|January 22, 2026
Comparative pharmacokinetics of levodopa-carbidopa intestinal gel infusion and foslevodopa-foscarbidopa continuous subcutaneous infusion therapies in advanced Parkinson's diseaseYohei Mukai, Junko Takei, Juri Nomoto, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Brain and Nerve = Shinkei Kenkyu No Shinpo|October 7, 2021
[Intravascular Large B-cell Lymphoma]Shinji Oda, Masaki Takao
Chemical Communications (Cambridge, England)|February 7, 2008
A novel chiral porous metal-organic framework: asymmetric ring opening reaction of epoxide with amine in the chiral open spaceKoichi Tanaka, Shinji Oda, Motoo Shiro
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|September 1, 2024
[Risk Factors Analysis for Hypermagnesemia with Magnesium Oxide]Shinji Oda, Takayuki Miyoshi, Kenshi Takechi, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|March 1, 2026
[Relationship between Hypercalcemia and Renal Function with Eldecalcitol]Shinji Oda, Takayuki Miyoshi, Kenichi Furuta, et al.
European Journal of Clinical Pharmacology|April 3, 2023
Association between nocturnal falls and hypnotic drug use in older patients at acute care hospitalsShinji Oda, Kenshi Takechi, Satoru Hirai, et al.
Rinsho Shinkeigaku = Clinical Neurology|May 20, 2021
[Amyotrophic lateral sclerosis with muscle weakness and dropped head during the course of Parkinson's disease: an autopsy case]Shinji Oda, Terunori Sano, Noriko Nishikawa, et al.
Journal of Pharmaceutical Health Care and Sciences|October 28, 2025
Risk factors for falls in patients treated with chemotherapyShinji Oda, Kenshi Takechi, Chiyuki Tsukui, et al.
Brain & Development|November 16, 2021
A case of delayed diagnosis of Becker muscular dystrophy due to underlying developmental disordersShinji Oda, Madoka Mori-Yoshimura, Yasushi Oya, et al.
Parkinsonism & Related Disorders|January 22, 2026
Comparative pharmacokinetics of levodopa-carbidopa intestinal gel infusion and foslevodopa-foscarbidopa continuous subcutaneous infusion therapies in advanced Parkinson's diseaseYohei Mukai, Junko Takei, Juri Nomoto, et al.
Pageof 1